首页 | 本学科首页   官方微博 | 高级检索  
检索        

降低急性心梗急诊PCI后无复流/慢血流方法探讨(附89例报告)
引用本文:丁浩,程勇,张荣林,张志勇,程春齐,王万虹,骆十姐,吴静,王苗苗.降低急性心梗急诊PCI后无复流/慢血流方法探讨(附89例报告)[J].心血管康复医学杂志,2012,21(6):616-618.
作者姓名:丁浩  程勇  张荣林  张志勇  程春齐  王万虹  骆十姐  吴静  王苗苗
作者单位:丁浩 (南京鼓楼医院集团宿迁市人民医院心内科,江苏宿迁,223800); 程勇 (南京鼓楼医院集团宿迁市人民医院心内科,江苏宿迁,223800); 张荣林 (南京鼓楼医院集团宿迁市人民医院心内科,江苏宿迁,223800); 张志勇 (南京鼓楼医院集团宿迁市人民医院心内科,江苏宿迁,223800); 程春齐 (南京鼓楼医院集团宿迁市人民医院心内科,江苏宿迁,223800);王万虹 (南京鼓楼医院集团宿迁市人民医院心内科,江苏宿迁,223800); 骆十姐 (南京鼓楼医院集团宿迁市人民医院心内科,江苏宿迁,223800); 吴静 (南京鼓楼医院集团宿迁市人民医院心内科,江苏宿迁,223800); 王苗苗 (南京鼓楼医院集团宿迁市人民医院心内科,江苏宿迁,223800);
摘    要:目的:探索降低急诊PCI后无复流/慢血流的方法。方法:急诊PCI病人分两组:常规PCI组(49例),出现无复流/慢血流后予以血小板Ⅱb/Ⅲa受体拮抗剂(替罗非班)和/或血栓抽吸导管处理;预处理组(30例)在球囊扩张前予以替罗非班和/或血栓抽吸预处理。结果:预处理组未出现无复流/慢血流;与常规PCI组比较,预处理组无复流/慢血流发生率明显降低(10.2%比0,P〈0.05)。结论:在常规药物治疗的基础上预防性使用替罗非班和/或血栓抽吸可以明显降低急诊PCI术后无复流/慢血流的发生。

关 键 词:心肌梗塞  血管成形术  经腔  经皮冠状动脉  血栓形成

Explore of method decreasing no-reflow/slow blood flow in patients with acute myocardial infarction after emergency PCI(report of 89 cases)
DING Hao,CHENG Yong,ZHANG Rong-lin,ZHANG Zhi-yong,CHENG Chun-qi,WANG Wan-hong,LUO Shi-jie,WU Jing,WANG Miao-miao.Explore of method decreasing no-reflow/slow blood flow in patients with acute myocardial infarction after emergency PCI(report of 89 cases)[J].Chinese Journal of Cardiovascular Rehabilitation Medicine,2012,21(6):616-618.
Authors:DING Hao  CHENG Yong  ZHANG Rong-lin  ZHANG Zhi-yong  CHENG Chun-qi  WANG Wan-hong  LUO Shi-jie  WU Jing  WANG Miao-miao
Institution://Department of Cardiology,People′s Hospital of Suqian City of Nanjing Drum Tower Hospital Group,Suqian,Jiangsu,223800,China
Abstract:Objective: To study method decreasing no-reflow/slow blood flow after emergency percutaneous coronary intervention (PCI). Methods: A total of 79 patients undergoing emergency PCI were divided into two groups: routine PCI group (n = 49), received platelet IIb/III a receptor antagonist (tirofiban) and/or thrombus aspiration catheter treatment when noreflow/slow blood flow occurred; Preconditioning group (n = 30), received tirofiban and/or thrombus aspiration preconditioning before balloon dilation. Results.. There was no case of no- reflow/slow blood flow in preconditioning group; compared with routine PCI group, the incidence rate of no- reflow/slow blood flow significantly decreased (10.2% vs. 0, P〈0.05) in preconditioning group. Conclusion: Based on routine drug treatment, prophylactic use of tirofiban and/or thrombus aspiration can significantly decrease incidence rate of no- reflow/slow blood flow after emergency percutaneous coronary intervention.
Keywords:Myocardial infarction  Angioplasty  transluminal  percutaneous coronary  Thrombosis
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号